Medical Breakthroughs

Cancer is a disease caused by uncontrolled growth offunctions to manufacture antibodies for a reliable
cells. There are several types of cancer from head toimmune system, an enzyme called
the bottom part of our body. Tumors are excessiveBruton-tyrosine-kinase is essential. Preclinical
tissue found in the organ. Tumors can be malignantobservations showed the ability of PCI-32765 to
leading to cancer and benign tumor which can beprevent growth of cancer cells at the same time
treated.eliminate the cancer cells and eventually cause cell
Tumors normally occur in the cells of the body anddeath.
eventually grow to uncontrollable sizes until itAnother great news is about the release of a new
accumulates all cells within the organ leading to adrug to treat a cancer that was approved by FDA
more serious condition called cancer. Doctors andon May 2010 is Provenge, a new treatment for
medical experts are in the verge of finding out aprostate cancer that was originally developed by
more appropriate, safer, and a cheaper cure andStanford researchers in the 1990s.
treatment against cancer.Provenge uses immune cells of the body to
Cancer researchers are not stopping on researchingrecognize and then fight cancer, which usually cells
medications or therapy for cancer patients. There is adon't recognize as a foreign threat. The body will be
new cancer treatment that will give hope totargeted of the treatment and it will be leading
lymphoma and leukemia patients. Before, patientsdirectly to the immune cells which are pre-defined.
who are diagnosed to have leukemia, or blood cancerThe therapy will target existing advanced stage
have less probability of survival, now with the latestcancers and is not preventative like traditional tetanus
medical news for cancer treatment, will improve thevaccines or measles vaccines. Unlike other types of
survival rate of these types of cancer.therapies, the use of Provenge will add added hope
In the 26th of February, 2010, the news straightto a prostate cancer patient. It will also be directed
from the medical researchers have drawn highto the cancer cells while aiding the impacted cells,
expectations for a newest therapy for cancerthus enabling the other living cells to perform normal
patients with specified cancer types such as leukemiafunctions without interrupting them.
and lymphoma. They were able to develop a newAccuracy and effectiveness is also tested at the
drug which will be an effective aid towardssame time, the extent of the therapy, its precaution,
lymphoma and leukemia.and side effects. Although this is such a go news, we
The PCI-32765 drug is being tested and analyzed in astill have to itemize all the possible effects and
clinical trial labeled as Phase I by the Virginia G. Piperaftershock of the process to lessen them if not
Cancer Center with the collaboration of the Clinicaltotally get rid of it.
Division of the Translational Genomics ResearchHighly industrialized countries will be the one to create
Institute (TGen). There were clinical trials and testingsample operations since the testing itself are costly.
done to measure the effectiveness and safety ofSurely, these breakthroughs in medical sciences in
the new drug prior to approval by the United Statestreating cancer is commendable and should be taken
Food and Drug Administration.into consideration to reduce mortality rate due to
PCI-32765 drug targets the cellular abnormalities ofcancer.
lymphoma cells. To maintain B-lymphocytes that